中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    VANFLYTA (quizartinib) tablets
    VANFLYTA (quizartinib) tablets
    departments：血液科
    drug：片剂
    Active：QUIZARTINIB DIHYDROCHLORIDE
    indication：VANFLYTA用于治疗新诊断的成年患者急性髓性白血病（AML）。
    Licensor：Daiichi Sankyo, Inc.
    Approved Country/Region：美国
    Approval time：2023-07-20